Emerging patents in the therapeutic areas of glioma and glioblastoma
{{output}}
Introduction: Glioblastoma multiforme (GBM) is the most common and aggressive malignant glioma, with patients having a median survival of just over one year. Current chemotherapies, with surgery and radiotherapy, provide only min... ...
